Tag Archives: medical device labeling automation

Crimson Life Sciences Becomes Part of TransPerfect Medical Device Solutions

TP_MedicalDeviceSolutions_stacked_cmykOn Monday, 6/1, Crimson Life Sciences officially becomes part of  TransPerfect Medical Device Solutions. Here’s more information from the client notification:

You may be wondering: why the change? The language and content needs of the medical device industry have evolved significantly over the years, and the TransPerfect family of companies has met those changes by developing a wide range of services and technologies to meet the specific needs of device makers. A majority of our work now rests on integrated solutions that help clients reduce cost and risk through process automation and redesign, including:

  • Process Automation Technology
  • Labeling Automation Solutions
  • Validated XML Publishing Systems
  • Automated Website Localization
  • Software Design, Translation, Verification, and Testing
  • E-Learning Development and Localization
  • And more!

Throughout our 23 years in business, Crimson has come to be known as the most quality-focused translation provider in the industry. Our commitment to this goal has not changed, but our name now reflects our full range of integrated solutions for device makers.

It has been our great honor to work with our clients in the medical device industry for the past quarter-century. We look forward to providing innovative services, technologies, and systems as TransPerfect Medical Device Solutions.

 

 

Advertisements

Eating Our Young: XML Eliminates DTP Revenue for Translation Providers…and That’s a Good Thing

You have to admit, William Blake had a flair for the bizarrely dramatic – consider his rendition of Kronos (father of the Greek gods) devouring one of the Olympians.
Translation companies might have the same reaction to eliminating DTP revenue as someone seeing this Blake painting for the first time. After all, DTP expense can account for up to 50% of the total localization budget for some manufacturers – that’s a lot of revenue for a service provider to give up.
We had a different reaction to XML for a few reasons:
> Two of the leading XML publishing systems, Vasont Systems and Astoria Development, are part of TransPerfect Medical Device  Solutions – we have the tools and know-how to implement these systems.
>  We know that approximately 50% of the error risk in a translation production process is due to formatting – eliminate formatting and you eliminate risk.
> It’s just the right thing to do: manufacturers are working to expand their markets by lowering unit costs so that they can serve more patients – helping them to lower costs is the same thing as expanding access to lifesaving devices for patients around the world.
So, yes, when it comes to DTP revenue we ARE “eating our young” – but it’s a good thing for manufacturers AND for patients.

“Scots Wha’ Hae” and Radical Localization for Medical Device Marketing Material

‘Scots, wha hae wi Wallace bled,

Scots, wham Bruce has aften led,

Welcome tae yer gory bed,

Or tae victorie.

As a Celtic Studies major in college and one-time resident of Scotland, I’ve watched with keen interest the impending Scottish independence vote. After 300+ years of union, it’s shocking to think this vote is too close to call (with an incredible 95%+ voter turnout). However, it’s also a very good example of the persistence of regional culture and identity in Europe – and underscores the importance of localizing (not just translating) your marketing content.

Marketing messages designed for the US may not resonate (or even translate) into e.g. French, German, or Turkish markets. That’s why many manufactures are now looking at “radical localization” – a complete rewrite of marketing content for local markets – only “guided” by the English original.

Of course, in these instances, it’s important to have a control in place to ensure that the localized material is acceptable from a Regulatory point of view. This is where technology can help: TransPerfect Medical Device Solutions offers clients  validated technology (Translation Review Portal; TRP) for easy, online review and auditable commenting of translated material – there’s even a preview function so you can see your material in formatted context.

If you *do* need to translate your content into EU target languages, TRP also makes a great platform for your overseas contacts to review and comment on translation quality – there’s even a built-in grading and scoring system so you can track results.

So, whether it’s review of translation accuracy or review of “radical localization” for compliance, technology from TransPerfect Medical Device Solutions can help. And, if Scotland *does* become independent and requires Gaelic for labeling, you’ll be ready!  😉

P.S. Although, romantically, I would love to see an independent Scotland, I know from a practical perspective that continued union is in Scotland’s best interest: No thanks!

Worldwide Medical Costs Declining (in part) Thanks to XML!

OK – maybe the recently reported, substantial drop in worldwide medical costs isn’t entirely due to XML publishing technologies…but it’s one good example. All across the healthcare industries, companies and providers are adopting new methods and technologies that are helping them reduce cost and – finally – contain runaway expenses.

In the medical device industry, content-related costs have been growing rapidly over the past 20 years. But recently, companies like Medtronic, J&J, and Stryker have adopted XML publishing as a powerful way to reduce turnaround, cost, and risk – making their products more price-competitive around the world.

For instance, Medtronic implemented an XML content management system from our Vasont division to cut the time and cost of their translation/localization process by 50% – as one Technical Communications Manager there said recently, “We process ten times more content with the same headcount – this wouldn’t be possible without XML.”

XML is just one of the automation technologies offered by TransPerfect Medical Device Solutions to help manufacturers lower their content cost and risk and increase productivity – or, automate the entire labeling process with our EnCompass system. At TransPerfect, we’re helping to drive down the cost of healthcare – and increase profitability for our clients!

What Do Walgreens and Medical Device Content Management Have in Common?

WalgreensAnswer: both employ automation to reduce cost. At Walgreens,  software algorithms are being used to help guide and standardize patient treatment. Based on “big data” from over 100 million patients, the pharmacy chain is proving that professional services can be semi-automated with helpful results. You can read about it here.

A similar scenario is playing out in the medical device industry. Manufacturers are learning that they can automate content by structuring it with XML/DITA. The process requires patience and effort (though easier than developing a software system for patient treatment). However, it yields big savings and risk reduction. Starting with the XML systems provided by  Astoria Software and Vasont Systems, and continuing through the translation process automation technologies of the GlobalLink suite, TransPerfect Medical Device Solutions has the services, know-how, and technologies necessary to automate your content and achieve sustainable cost and risk reduction.

The Most Popular Post Ever

According to Crimson Audit, Review, & Consulting, in over 4 years, their most popular post (by far) has been this:  Labeling Errors are Leading Cause of Device Recall.

With the growing interest in XML publishing in the medical device industry, this information is now more relevant than ever.  Our Astoria and Vasont divisions provide validated systems for device makers like GE Healthcare, Medtronic, and J&J because these systems can reduce localization costs by 40%…but, as you might guess, this level of savings comes at a cost.

The strength of these systems is that they manage content in a “single source” – there is one version of a content chunk (topic) which is reused in other publications or channels. However, if the content contains an error (in the English source or translated target), that error gets replicated out multiple times – this is a classic “propagation risk” and it has very real implications for labeling accuracy and device recall.

The best solution is also a classic: the quality systems principle of “quality at the source”. For translation, it means that appropriate risk management must be employed to produce XML -based translated content. This not only minimizes propagation risk, it also reduces the risk of device recall due to labeling errors.

The Perscription for the $500,000,000 Industry Headache

Industry estimates put the total cost of content for the medical device industry at over $1 billion. Sadly, research also tells us that over 40% of this cost is unnecessary, due largely to process inefficiencies and fragmentation:
http://finance.yahoo.com/news/crimson-life-sciences-presents-400-132500261.html

Because content is the lifeblood of the medical device industry, a fragmented content strategy can create lots of “noise” – disruptions, delays, complaints and cost-overruns in your labeling or documentation processes. This, in turn, contributes an estimated $400 million in excess industry costs every year…doctor, this patient needs your help!

The proven treatment includes best process practices and validated technology for medical device content creation, management, translation, and publication. That’s EnCompass.